iSpecimen Inc. Reports Director Changes and Compensation Adjustments
Ticker: ISPC · Form: 8-K · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: management-change, compensation
TL;DR
iSpecimen board shakeup and pay changes filed.
AI Summary
On November 7, 2024, iSpecimen Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates a shift in leadership and potential adjustments to how key personnel are compensated.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future financial performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and financial stability.
Key Players & Entities
- iSpecimen Inc. (company) — Registrant
- November 7, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40501 (filing_id) — SEC File Number
- 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal executive offices
- (781) 301-6700 (phone_number) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors?
The filing indicates changes related to the 'Departure of Directors or Certain Officers' and 'Election of Directors', but the specific names and details of these changes are not provided in the excerpt.
What are the key aspects of the compensatory arrangements mentioned?
The filing notes 'Compensatory Arrangements of Certain Officers', suggesting adjustments or new plans for executive pay, though specific details are not in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 7, 2024.
What is iSpecimen Inc.'s state of incorporation and principal executive office address?
iSpecimen Inc. is incorporated in Delaware and its principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.
What is the SEC file number for iSpecimen Inc.?
The SEC file number for iSpecimen Inc. is 001-40501.
From the Filing
0001104659-24-116923.txt : 20241112 0001104659-24-116923.hdr.sgml : 20241112 20241112171511 ACCESSION NUMBER: 0001104659-24-116923 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20241107 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241449838 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 tm2428277d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-11-07 2024-11-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): November 7, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road, Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.   On November 8, 2024, iSpecimen Inc. (the “Company”) and Tracy Curley mutually agreed to end Ms. Curley’s employment as Chief Executive Officer, Chief Financial Officer and Treasurer of the Company. The parties dispute whe